Featured Research

from universities, journals, and other organizations

Can medication slow growth of abdominal aortic aneurysms?

Date:
August 29, 2013
Source:
University of Michigan Health System
Summary:
Non-invasive treatment of abdominal aortic aneurysm clinical trial (N-TA^3CT) investigates what could be the first medical therapy available in the high-stakes course of treating aortic aneurysms.

A new clinical study at the University of Michigan Health System will test the ability of a once daily dose of doxycycline to reduce the growth of small abdominal aortic aneurysms.

An abdominal aortic aneurysm is a bulge in a section of the aorta, the body's main artery. The risk of a rupture is unpredictable, and few patients survive when they do.

The U-M's Frankel Cardiovascular Center is the only health center in the state selected to participate in the national clinical trial investigating what could be the first medical therapy available in the high-stakes course of treating aneurysms.

Surgical repair may become necessary when an aortic aneurysm reaches a certain size or interferes with surrounding blood vessels or organs, but surgery is not an option for all aortic patients.

"It's a really exciting trial examining options for the patients who are relegated to watching and waiting," says University of Michigan vascular surgeon Jonathan Eliason, M.D., associate professor of surgery. "If this medicine is effective in slowing aneurysm growth rates, it could revolutionize our treatment of AAAs."

The clinical trial Non-Invasive Treatment of Abdominal Aortic Aneurysms (N-TA^3CT) will determine whether treatment with doxycycline, a microbial drug that in animal studies inhibited the action of matrix metalloproteinase (MMP), an enzyme linked to the development of AAAs, will lead to reduced growth of an aneurysm.

"The aim is to see if the data gained from animal studies for slowing aneurysm growth holds true for humans," says Eliasion.

A normal abdominal aorta is approximately 2.0 cm in diameter -- about the size of a quarter -- but an aneurysm puts stress on the artery walls. The risk of rupture for an AAA over 5.5 cm in diameter is 9 to 10 percent, and over 7 cm the risk increases to more than 30 percent.

AAA is more common in men and in those age 65 and older. According to the Centers for Disease Control and Prevention, the most effective way to prevent aortic aneurysms is reducing risk factors including quitting smoking and controlling high blood pressure and high cholesterol.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Can medication slow growth of abdominal aortic aneurysms?." ScienceDaily. ScienceDaily, 29 August 2013. <www.sciencedaily.com/releases/2013/08/130829092646.htm>.
University of Michigan Health System. (2013, August 29). Can medication slow growth of abdominal aortic aneurysms?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/08/130829092646.htm
University of Michigan Health System. "Can medication slow growth of abdominal aortic aneurysms?." ScienceDaily. www.sciencedaily.com/releases/2013/08/130829092646.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins